Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Government of India

    Tag: Government of India

    You Searched For "Government of India"
    With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemption

    With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption

    Medical Dialogues Bureau21 Nov 2019 12:09 PM IST
    New Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Medical Dialogues Bureau5 July 2019 5:58 PM IST
    As per provisions of DPCO, all manufacturers of Scheduled medicines (branded or generic) have to sell their products within the ceiling price fixed by...
    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

    Farhat Nasim28 Jun 2019 4:44 PM IST
    New Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Procedure for approval of FDC drugs: CDSCO releases notification; Details

    Meghna A Singhania24 May 2019 6:12 PM IST
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed drug manufacturers and all the...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Meghna A Singhania5 March 2019 5:01 PM IST
    New Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
    NPPA fixes retail price of Emcure pharma

    NPPA fixes retail price of Emcure pharma's HIV drug

    Meghna A Singhania17 Feb 2019 9:30 AM IST
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    Meghna A Singhania3 Feb 2019 11:16 AM IST
    New Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry

    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry

    Farhat Nasim18 Jan 2019 10:59 AM IST
    According to the notification, some of the fixed dose combination drugs that have been banned include antibiotics like Cefglobe OZ, Taxim -OZ, drugs...
    Launch of User Manual on SUGAM portal: CDSCO

    Launch of User Manual on SUGAM portal: CDSCO

    Medical Dialogues Bureau2 Dec 2018 12:00 PM IST
    New Delhi: Through a public notice released on 29.11.2018 Central Drugs Standard Control Organisation(CDSCO) has announced the launch of a User...
    Pharma Export do not need NOC: CDSCO

    Pharma Export do not need NOC: CDSCO

    Ruby Khatun Khatun23 March 2018 4:50 PM IST
    New Delhi: In order to improve ease of doing business Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare,...
    Launch new drugs without prior price approval: NPPA issues guidelines

    Launch new drugs without prior price approval: NPPA issues guidelines

    Ruby Khatun Khatun2 Dec 2017 12:25 PM IST
    Through a recent notification the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok